Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Abbott decides to withdraw 2 stent types from India

      Abbott decides to withdraw 2 stent types from India

      supriya kashyap kashyap22 April 2017 9:47 AM IST
      New Delhi : Healthcare major Abbott has decided to withdraw two types of stents from the Indian market in the wake of drug price regulator National...
      Pfizer subpoenaed in US intravenous saline solution probe

      Pfizer subpoenaed in US intravenous saline solution probe

      supriya kashyap kashyap21 April 2017 11:02 AM IST
      Boston : Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investigation focusing on drug...
      Sandoz must face wrongful death claim over heart drug - judge

      Sandoz must face wrongful death claim over heart drug - judge

      supriya kashyap kashyap21 April 2017 10:57 AM IST
      Novartis AG's Sandoz unit must face a wrongful death lawsuit accusing it of promoting a generic version of Pfizer Inc's cardiac arrhythmia drug...
      NPPA to penalise companies offering freebies on stent sales

      NPPA to penalise companies offering freebies on stent sales

      supriya kashyap kashyap21 April 2017 10:55 AM IST
      New Delhi : Drug price regulator NPPA warned coronary stent manufacturing firms of strict action if they are found giving freebies on sale of the...
      As AstraZeneca chases rivals, immuno-oncology gets complicated

      As AstraZeneca chases rivals, immuno-oncology gets complicated

      supriya kashyap kashyap21 April 2017 9:57 AM IST
      London : Three years after Pfizer's failed bid for AstraZeneca, the British drug maker aims to prove in the coming weeks that its cancer immunotherapy...
      Alembic Pharma gets tentative USFDA nod for antidepressant

      Alembic Pharma gets tentative USFDA nod for antidepressant

      supriya kashyap kashyap20 April 2017 12:19 PM IST
      New Delhi : Alembic Pharmaceuticals has received tentative approval from the US health regulator for vilazodone hydrochloride tablets used for...
      Standard Chartered PE sells 1.41 percent stake in Fortis for Rs139 crore

      Standard Chartered PE sells 1.41 percent stake in Fortis for Rs139 crore

      supriya kashyap kashyap20 April 2017 12:01 PM IST
      New Delhi: A foreign institutional investor offloaded 1.41% stake in Fortis Healthcare for over Rs 139 crore through an open market transaction.As per...
      Glenmark gets tentative USFDA nod for anti-coagulant drug

      Glenmark gets tentative USFDA nod for anti-coagulant drug

      supriya kashyap kashyap20 April 2017 11:51 AM IST
      New Delhi : Glenmark Pharmaceuticals has received tentative nod from the US health regulator for anticoagulant medication Dabigatran Etexilate...
      Aurobindo Pharma down 4 percent on USFDA observations for Hyderabad unit

      Aurobindo Pharma down 4 percent on USFDA observations for Hyderabad unit

      supriya kashyap kashyap20 April 2017 11:40 AM IST
      New Delhi : Shares of Aurobindo Pharma fell by nearly 4 per cent after the company said that US health regulator has issued observations for its Unit...
      Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

      Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

      supriya kashyap kashyap20 April 2017 11:40 AM IST
      Mumbai : Piramal Enterprises Consumer Products business has partnered with the Indian Pharmaceutical Association (IPA), to promote responsible...
      Medtronic Signs Definitive Agreement to sell Patient Monitoring,Recovery Division to Cardinal Health for $6.1 Billion

      Medtronic Signs Definitive Agreement to sell Patient Monitoring,Recovery Division to Cardinal Health for $6.1 Billion

      supriya kashyap kashyap20 April 2017 11:40 AM IST
      Dublin : Medtronic plc announced that it has entered into a definitive agreement with Cardinal Health Inc. to sell its Patient Care, Deep Vein...
      Sebi slaps Rs 8 lakh fine on Aanjaneya Lifecares officials

      Sebi slaps Rs 8 lakh fine on Aanjaneya Lifecares officials

      supriya kashyap kashyap20 April 2017 9:06 AM IST
      New Delhi : Markets watchdog Sebi imposed a total penalty of Rs 8 lakh on Aanjaneya Lifecares five senior officials for not complying with model code...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok